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Introduction: Autistic spectrum disorders (ASD) don't have the same etiology. Platelet
hyperserotonemia remain the most common neurochemical abnormality in these
patients. The main producer and storage of peripheral serotonin are enteric enterochro-
mafﬁn cells – serotonin cells. Platelet hyperserotonemia may result from disorders in the
synthesis and/or release of enteric serotonin. An increased number of people with ASD
have gastrointestinal disorders. Some of them have a serotonergic background. Aim: The
aim was to assess the serotonin cells in the duodenal mucosa of patients with ASD.
Material and methods: Study group: 30 children with ASD, including 73% with duodenitis
chronica. Control group (patients without ASD): 45 patients, 56% with duodenitis chronica.
Immunohistochemical assessment of the number of serotonin cells was performed.'
Results: Children with ASD and duodenitis have fewer serotonin cells than autistic child-
ren with a normal picture of the duodenum. Children with ASD and chronic duodenitis
have fewer serotonin cells than patients from the control group. Patients from the con-
trol group, suffering from chronic duodenitis have an increased number of serotonin cells
in relation to children without inﬂammatory lesions in the duodenum. Conclusions: The
serotonergic proﬁles of the GI tract of autistic patients and their peers without autistic
symptoms are different. In the course of chronic duodenitis in patients with ASD the num-
ber of serotonin cells falls while in persons without autistic features it increases signiﬁ-
cantly. Chronic duodenitis contributes to an increase in the number of serotonin cells in
persons without autistic features while decreasing it in patients with ASD.
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Serotonergic disorders in ASD were pronounced after the
conduction of the following examinations: biochemical,
pharmacological, behavioural analyses, molecular biology
concerning serotonin receptor and transporter, serological
and neuroimaging diagnosis (positron emission tomography,
PET; functional MRI, fMRI) [1–6]. Estimations of the level of
5HT in peripheral blood in autistic patients in the develop-
mental age indicate prepubescent platelet hyperserotonine-
mia [7, 8]. In adult patients with ASD, lower than the control
values with a decrease in platelet serotonin reuptake have
been observed [9]. Simultaneously conducted neuroimaging,
pharmacological (SSRI) and behavioural proﬁle examinations
suggest central hyposerotoninemia [10]. So far the signiﬁ-
cance of platelet (PLT) hyperserotoninemia has not been
established. The serotonergic proﬁle changes as it grows
(function of receptor/neurotransmitter systems, types of
5HT receptors, their activity, number, location, serotonin
level). In autistic persons this process is probably disturbed
from the neurogenesis [8, 10].
In postnatal life, due to the blood–brain barrier, periphe-
ral and central 5HT are two different deposits. The main
producer and a storeroom for the peripheral 5HT are the
intestinal enterochromafﬁn cells (ECH), and speciﬁcally their
subgroup referred to as serotonin cells (ECH 5HT). 2% of 5HT
in our bodies is stored in the CNS, 95% in the intestines
(90% in ECH and 10% in the enteric nervous system – ENS),
the remaining part is in blood PLT [11]. 5HT is mainly
secreted paracrinely from ECH 5HT onto the gastrointestinal
(GI) mucosa. It penetrates into the intestinal lamina propria
(it impinges on the peripheral nerves' endings and affects
the enteric immune system) and diffuses into the peripheral
blood. Small amounts can be found in intestinal lumen
(trace amount detected in faeces) [12]. 5HT secreted from
ECH is subject to active SETR-mediated reuptake. Molecu-
larly identical SERT is present on blood PLT, cells of the
mucosa of the intestines and lungs, and in the central,
peripheral and enteric nervous system. It has been suspec-
ted that it is SERT that is responsible for serotonergic
disorders in autistic persons. Conducted molecular analyses
do not conﬁrm the above theory [13]. Free 5HT in peripheral
blood is subject to ﬁrst pass metabolism in the liver and to
a lower degree in the lungs. It is only the 5HT, hidden in
blood PLT that avoids the metabolism [12]. Due to the few-
day half-life (T1/2) of 5HT and the short time of life of PLT,
the PLT level of 5HT reﬂects the current availability of 5HT
for PLT. It should be accepted that PLT 5HT is a reﬂection of
the intestinal production [11]. 5HT is broken down in the
body by MAO – A into 5-hydroxyindoleacetic acid (5HIAA),
which is subsequently extracted from urine. An indirect
proof of an increased serotonin turnover is increased
extraction of 5-HIAA [14].
Recently an increased number in ASD patients suffering
from problems relating to the GI tract in comparison to the
population of persons without the autistic features has been
observed. The most common disorders include abdominal
pains, disorders in gastrointestinal motor activity and nutri-
tional problems. Both endoscopic and histopathologicalexaminations have conﬁrmed on several occasions an
increased number of patients with autistic disorders, suffe-
ring from chronic inﬂammation of the abdomen, the duode-
num and the colon [15–18]. Moreover, autistic patients
present the signs of microbiological gut dysbiosis [19, 20].
Serotonin is one of the GI transmitters (signaling mole-
cule), which plays a vital role in the perception, motor
activity and secretion of the GI tract. The role of 5HT in the
ailments (dyspepsia), motor activity disorders (vomiting,
diarrhoea, constipation) and gastrointestinal disorders
(mainly functional GI disorders, irritable bowel syndro-
me = IBS) has been proven [21, 22]. The clinical picture of
serotonergic disorders corresponds with GI problems of the
patients with ASD.
Janusonis conducted a theoretical analysis of biological
parameters related to the serotonin system. Using
a mathematical model he proved that the content of 5HT in
blood platelets depends on the PLT reuptake of serotonin, the
amount of free plasma serotonin subject to the ﬁrst pass
metabolism in the liver and lungs, intestinal production of
serotonin and the volume of the enteric wall [7]. Because,
theoretically, the cause of platelet hyperserotoninemia may
be a disorder of the synthesis of serotonin and/or of the
release of the enteric serotonin, we made an attempt to
assess the proportion of the ECH 5HT cells in the duodenal
mucosa.
Material and methods
Characteristics of the study and control group: The total of
75 patients were included in the retrospective analysis: 30
children with autistic spectrum disorders (ASD) and 45 of
their peers without the symptoms of ASD (not – ASD). The
study was retrospective. The study followed the permission
of the Bioethic Committee of the SMU in Katowice (number
of the consent L.dz.NN-013-42/03).
The children were patients of the Department of Gastroen-
terology of the Clinic of Paediatrics of the SMU in Katowice
between 2004 and 2006. During clinically indicated hospitali-
sation, the upper GI endoscopy and the collection of speci-
mens of the mucosa in the descending part of the duodenum
were performed. The study group (ASD) and the control group
(non-ASD) are homogenous in terms of sex and age.
Study group: a total number of 30 persons (16 AD/14 AA);
males n = 19, females n = 11; age between 3 and 13 years old;
average age of 8 years; in 8/30 persons a normal picture of
the mucosa was reported (ASD-SN) and in 22/30 of persons
were presented with symptoms indicating an inﬂammation
(chronic duodenal inﬂammation in 9 patients, chronic
duodenal inﬂammation with inﬁltration of eosinophiles in
13 persons; ASD-Dch).
Control group: a total number of 45 persons; males n = 28,
females n = 17; age between 3 and 13 years; average age of
8 years; the patients from the control group were selected
retrospectively based on the relevant medical documenta-
tion; they were patients without ASD, where a histopatho-
logical examination revealed a normal picture of the duode-
nal mucosa, corresponding with the picture obtained from
Fig. 1 – Serotonin in the duodenal mucosa. Enlarged 80
times
Fig. 2 – Serotonin in the duodenal mucosa. Enlarged 200
times
Table I – Indication of the cell/tubule in the examined
groups
Autistic children Control groups
A–SN A–Eo + Dch SN Eo + Dch
N 8 22 20 25
Average 0.511 0.268 0.299 0.588
SD 0.327 0.192 0.160 0.314
Median 0.456 0.266 0.241 0.519
Comparison
NS – p > 0.05
p = 0.0436 p < 0.001
NS
p = 0.0041
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in 20 patients (non-ASD – SN), chronic inﬂammation of the
duodenum in 25 patients – including 13 with inﬁltration of
eosinophiles (non – ASD – Dch).
The excluding criteria for both groups included: celiac
disease (CD), intake of drugs affecting the level of 5HT
(within 30 days preceding the examination), active epilepsy,
the presence of an organic lesion in the area of the
abdomen and/or the pelvis, conﬁrmed by an imaging
examination, and having been on a gluten-free diet within
the 6 months preceding the examination.
Method
Both histopathological and immunohistochemical analyses
were performed of the specimens of the descending part of
the duodenum collected from the patients. The histopatholo-
gical analysis of the specimens of the duodenal mucosa and
the assessment of the content of serotonin in the mucosa
were performed at the Department and Institute of Pathologi-
cal Anatomy of the SMU. Immunohistochemical staining was
performed in accordance with the following scheme: parts of
tissue of the size of 4 mm cut on silanised slides were heated
up in a laboratory heater at 60 8C for one hour and next
deparafﬁnized in Xylene. At the next stage they were placed
in a number of alcohols of decreasing concentration, after
which the specimens were hydrated and the immunohisto-
chemical analysis commenced. Endogenous peroxydase was
inhibited for ﬁve minutes with 3% hydrogen peroxide. After
rinsing the sections in TBS solution (DAKO, cat. no S 3001)
they were incubated with the ﬁrst antibody (Serotonin, DAKO
cat. no 1530) at room temperature in a ready dilution. The
following stages of the immunohistochemical reaction were
performed using the LSAB 2 developing kit (DAKO cat. no
K 0675). DAB chromogen (DAKO cat. no K 3468) was used for
the colour developing reaction. After rinsing in distilled water
the sections were dyed with Meyer hematoxylin for one
minute and rinsed in running water for 15 min. The prepara-
tions were then dehydrated in a number of alcohols of
increasing concentrations, overexposed in Xylene and closed
in DPX. Dyed serotonin cells were counted in 5 ﬁelds of vision
when enlarged 200 times and numbered in relation to the
number of tubules in the same ﬁelds of vision. The obtained
results were compared to those obtained from the control
group – homogenous in terms of age and sex with the study
group, without developmental disorders, and for which the
performed endoscopy showed a normal picture of the GI
mucous membrane.
Results
Both histopathological and immunohistochemical analyses
were performed on the same section and by the same group
of pathomorphologists. The specialists had not been infor-
med about the patients' pervasive developmental disorders
when analysing the sections (Figs. 1 and 2).
Children with ASD and the inﬂammation of the duode-
num have signiﬁcantly fewer serotonin cells compared toautistic children with a normal picture of the duodenum
( p = 0.0436). In the control group patients with duodenitis
chronic have an increased percentage of serotonin cells
compared to children without the inﬂammation of the
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the autistic features, with pronounced duodenitis chronica
have considerably more serotonin cells that autistic children
with the same pathology ( p = 0.0041) (Table I).
Discussion
Serotonin is a signalling molecule of both central and
peripheral character. Specialists that are mainly concerned
with it are neurologists, psychiatrists and gastrologists.
Dysfunctions of serotonin transporters/receptors and an
abnormal level of the enteric serotonin may be the cause of
nausea, abdominal pains and malfunctions of the motor
activity of the upper and lower GI tract [11, 23]. As has been
determined, the level of serotonin, the number of the ECH
cells, TpH – 1 and SERT change depending on the level of
the GI tract [24, 25]. A number of scientists have analysed
the percentage of ECH cells in patients with various GI
disorders. The related research concerns mainly the asses-
sment of the colonic mucosa and was conducted in the
population of adults, therefore it is difﬁcult to compare
them to the results obtained during our research. Patients
examined by us, without autistic symptoms and with
histopathologically conﬁrmed chronic duodenitis show
a statistically considerable increase in the number of ECH
cells, which partially conﬁrms the so far conducted observa-
tions. An inﬂammation within the GI tract leads to an
increase in the 5HT levels, in the number of ECH cells and
an increased secretion of 5HT from them [26, 27]. However,
according to some scientists, chronic and severe inﬂamma-
tion may cause a decrease in 5HT levels in the colonic
mucosa, with reduction of the number of ECH cells [23, 28].
Our patients – autistic with chronic inﬂammation of the
duodenum – showed a statistically signiﬁcant decrease in
the number of ECH cells. However, in this group it is difﬁcult
to establish the duration of symptoms.
The authors found two examples of research where the
number of ECH cells in biopsies of the upper GI tract were
analysed. However the patients presented in the research
were diagnosed with different primary disorders. Coleman
et al. [21] analysed the 5HT metabolism in the duodenal
mucosa of patients with untreated caeliac disease, conclu-
ding a signiﬁcant increase in the number of ECH 5HT cells
and the presence of other factors, manifesting the enteric
overproduction of serotonin. Faure et al. [23] analysed 5HT
transmission in patients at the developmental age with
functional dyspepsia, examining the number of ECH 5HT
cells in the mucosa of the corpus ventriculi and did not
report a difference in relation to the control group.
The obtained result, conﬁrming a signiﬁcant decrease in
the number of 5HT cells in the mucosa of autistic patients
with duodenitis chronica, is considered surprising for scien-
tists, as in patients with ASD a signiﬁcant increase in the
number of serotonin cells that could explain platelet hyper-
serotonemia, should be expected. Lesions within the area of
the colonic mucosa in the form of an increased number of
ECH cells and of T lymphocytes are characteristic for IBS.
Based on the experiments conducted on animals, it was
established that the inﬂammation of the intestines witha persisting high number of ECH 5HT cells depends on the
role of T lymphocytes in the inﬂammatory process [21, 26,
27]. In the immunohistochemical examinations of the biop-
sies of the duodenal mucosa of autistic children, lymphocy-
tic inﬁltrations with an increased number of T leukocytes
and deposits of G-immunoglobulin both within the area of
the epithelium and the membrane of the small intestine
were reported [17, 18]. So, it could have been assumed that
T-cell induced inﬂammation would result in an increase in
the number of ECH-5HT cells.
The reduction of the number of ECH 5HT cells may have
been induced by the intensity of the inﬂammatory process.
However the abnormalities observed in autistic patients in
endoscopic and histopathological examinations were not
signiﬁcantly intensiﬁed and remained disproportionate bet-
ween the disorders presented by the patients. At the same
time we know that serotonin is referred to as a molecule of
visceral oversensitivity [22]. In patients with gastrointestinal
disorders within the area of the duodenal wall, hyperseroto-
nemia (constant? temporary?) may be expected.
In 13 out of 22 autistic patients with histopathologi-
cally pronounced duodenitis chronica, eosinophilic inﬁl-
trations were observed in the duodenal mucosa. Both 5HT
and eotaxin are chemotactic factors of eosinophil granulo-
cytes [29]. However Trajkovski et al. observed considerably
higher levels of total Ig and speciﬁc antibodies against
nutrients in the classes of IgE, IgG and IgM compared to
the healthy population [30]. An increased number of
autistic patients with gastrointestinal disorders, coexisting
with allergy and food intolerance was also reported in our
previous research [5]. So at the moment the analysis of
the described phenomena remains difﬁcult and requires
further research.
The results presented by us are considered preliminary
research. We are aware of the existing limitations. As we
have presented, only the number of ECH 5HT cells was
analysed, without the measurement of other indicators. It
is also difﬁcult to compare our results to other scientiﬁc
research. The research that was available to us, refers
mainly to the examinations of the colon of adults, which
considerably hinders the comparison (the duodenum,
children). In order to answer our questions, it seems
crucial to repeat the analysis of ECH 5HT cells (together
with the assessment of the total number of ECH cells), to
determine the remaining 5HT parameters (including SERT
of the gastrointestinal mucosa and of platelets, the
content of 5HT in platelets of peripheral blood and enteric
mucosa), to conduct a more thorough immunohistochemi-
cal diagnosis of the specimen and a complex microbiolo-
gical diagnosis.
Conclusions
The serotonergic proﬁles of the GI tract of autistic patients
and their peers without autistic symptoms are different. In
the course of chronic duodenitis in patients with ASD the
number of serotonin cells falls while in persons without
autistic features it increases signiﬁcantly. Chronic duodeni-
tis contributes to an increase in the number of serotonin
p e d i a t r i a p o l s k a 8 8 ( 2 0 1 3 ) 2 3 0 – 2 3 5234cells in persons without autistic features while decreasing it
in patients with ASD.
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